Chinook Therapeutics (NASDAQ: KDNY)
Some price data may be temporarily unavailable.
Chinook Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Chinook Therapeutics Company Info
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
News & Analysis
Featured Article
2 Surging Healthcare Stocks With More Fuel in the Tank
These stocks climbed 74% and 78% over the past month and there could be more gains ahead.
Cory Renauer | Jun 20, 2023
Featured Article
Why Shares of Chinook Therapeutics Skyrocketed On Monday
The company, which specializes in treating kidney diseases, agreed to a buyout offer.
Jim Halley | Jun 12, 2023
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.